Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery-Reference-Cited by-同舟云学术

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery

Published:2014-08-11 Issue:3 Volume:115 Page:419-429
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Badani Ketan K.¹,Thompson Darby J.²³,Brown Gordon⁴,Holmes Daniel⁵,Kella Naveen⁶,Albala David⁷,Singh Amar⁸⁹,Buerki Christine¹⁰,Davicioni Elai¹⁰,Hornberger John¹¹¹²

Affiliation:

1. Columbia University Medical Center; New York NY USA

2. EMMES Canada; Burnaby BC Canada

3. Simon Fraser University; Burnaby BC Canada

4. Delaware Valley Urology; Mt. Laurel NJ USA

5. Kansas City Urology Care; Overland Park KS USA

6. The Urology and Prostate Institute; San Antonio TX USA

7. Associated Medical Professionals; Syracuse NY USA

8. University of Tennessee College of Medicine; Memphis TN USA

9. Erlanger Medical Center; Chattanooga TN USA

10. GenomeDx Biosciences; Vancouver BC Canada

11. Cedar Associates LLC; Menlo Park CA USA

12. Stanford University; Palo Alto CA USA

Funder

GenomeDx Biosciences

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12789/fullpdf

Reference26 articles.

1. Cancer Statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Pathologic findings at radical prostatectomy: risk factors for failure and death;Swanson;Urol Oncol,2007

3. NCCN Clinical Guidelines in Oncology (NCCN Guideline) Prostate Cancer. Version 1 2014 http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf

4. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911);Bolla;Lancet,2005

5. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial;Thompson;JAMA,2006

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the Combined Clinical Cell-Cycle Risk Score to Prognosticate Early Prostate Cancer Metastasis From Biopsy Specimens and Comparison With Other Routinely Used Risk Classifiers;JCO Precision Oncology;2024-02

2. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature;European Urology Oncology;2024-02

3. Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review;PLOS ONE;2023-03-10

4. Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus;International Journal of Radiation Oncology*Biology*Physics;2022-12

5. A Systematic Review of Decipher Genomic Classifier Risk Scores for Prostate Cancer in African-Americans;Current Pharmacogenomics and Personalized Medicine;2022-04